RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

IKS · Inventurus Knowledge Solutions Ltd · Software & Programming

IKS · Inventurus Knowledge Solutions Ltd · Software & Programming

₹1,757.2+0.4%

As of 05 Nov close

52-week range

52wk low ₹1,26252wk high ₹1,970

10.8% below 52-week high

52-week range: as of 05 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old

Revenue (latest Q)

₹894 Cr

Revenue YoY

PAT YoY

+27.9%

Operating margin

Revenue, last 8 quarters

P/E (TTM)

P/B

30.7

P/S (TTM)

8.7

Sector P/E

Not available from data source

Dividend yield

0.0%

CompanyP/EP/BNet marginROED/EDiv. yield
IKS (this stock)36.830.7+22.8%+27.3%0.270.0%
Tata Consultancy Services15.77.7+18.1%+48.0%8.93+2.9%
Infosys13.56.1+16.4%+33.2%0.1+4.6%
HCL Technologies16.77.4+13.0%+23.2%0.07+5.0%

Promoter

stable

FII

falling 1q

MF

2.92% (-0.26pp)

falling 1q

Insider trades

DateInsiderTypeQtyValue
27 Jun 2026Mundra HUFSELL6,776₹1.12 Cr
25 Jun 2026Mundra HUFSELL500₹8.54 lakh
31 Dec 2025Souvik ShyamSELL10,000₹1.65 Cr
30 Dec 2025Souvik ShyamSELL5,200₹87.1 lakh
27 Dec 2025MAYUR HARESHKUMAR SANGHVIBUY2,400₹19.78 lakh
27 Dec 2025VENKATKRISHNAN RAMAKRISHNANBUY2,000₹16.48 lakh
24 Dec 2025MAYUR PRAVINKANT SANGHVISELL6,000₹1.06 Cr
24 Dec 2025GAURAV JAINSELL1,00,000₹17.45 Cr
22 Dec 2025Abhay Kumar SrivastavaSELL6,000₹1.04 Cr
22 Dec 2025NIKHIL SHARMABUY4,200₹34.62 lakh
22 Dec 2025MURALIDHARAN RAMAMURTHY PILLAIBUY3,300₹27.2 lakh
20 Dec 2025MAHESH JAISALMERIABUY5,000₹14.75 lakh
19 Dec 2025MUNDRA .SELL4,000₹60 lakh
19 Dec 2025MUNDRA .SELL4,400₹74.8 lakh
19 Dec 2025MUNDRA .SELL3,246₹53.56 lakh
17 Dec 2025Abhay Kumar SrivastavaSELL5,278₹89.13 lakh
16 Dec 2025SAMEER S CHAVANSELL2,399₹40.66 lakh
09 Dec 2025NITHYA BALASUBRAMANIANBUY35,000₹2.88 Cr

Bulk/block deals

No bulk/block deals in the last 12 months.

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptPositive11 Aug 2026
View source filing →

Key takeaway: Inventurus Knowledge Solutions Limited (IKS) held its Q1 FY 2026-27 earnings conference call on August 6, 2026, to discuss its financial performance for the quarter ending June 30, 2026. Management provided an overview of the business, highlighting the integration of TruBridge and its unique position in the healthcare market. They reported a 21% year-on-year revenue growth, reaching INR 893 crores, with an EBITDA margin of 33%. Management emphasized the importance of their strategic pillars, including the development of an integrated system of action and record for rural healthcare. They also discussed the potential for cross-selling opportunities and the importance of maintaining a disciplined approach to acquisitions. The call concluded with management expressing confidence in achieving their long-term EBITDA goal of INR 3,000 crores by FY 2030, without significant equity dilution. The overall tone of the call was optimistic regarding growth prospects and strategic initiatives.

Management expressed confidence in growth and strategic initiatives.

Sourced from an exchange-filed transcript, dated 11 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive05 Aug 2026
View source filing →

Key takeaway: Inventurus Knowledge Solutions Limited (IKS) presented its financial results for the quarter ended June 30, 2026, highlighting a revenue of INR 8,936 million, representing a 21% year-over-year growth in INR and a 12% growth in USD. The company reported a 24% year-over-year increase in EBITDA, despite one-time acquisition costs, and a 22% profit after tax (PAT) margin. IKS emphasized its strong client relationships, with over 450 enterprise-level customers and 85% of revenues coming from repeat clients. The presentation outlined five strategic pillars for execution, focusing on technology integration and operational transformation. IKS received several awards, including recognition for excellence in investor relations and finance strategy. The document also noted a continued strong cash generation, with a 20.5% year-over-year increase in operating cash flow and a 26.9% increase in free cash flow.

Management emphasized strong growth and operational performance.

Sourced from an exchange-filed presentation, dated 05 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive20 May 2026
View source filing →

Key takeaway: The earnings conference call for Inventurus Knowledge Solutions Limited (IKS) on May 14, 2026, provided insights into the company's performance for Q4 FY26 and the full fiscal year. Management reported an 18.5% year-on-year revenue growth, reaching INR 857 crores, with a significant contribution from repeat customers. The company emphasized its strategic focus on leveraging AI to enhance operational efficiency and reduce administrative burdens for healthcare providers. Management discussed the integration of the AQuity acquisition and the ongoing development of their platform system of action, which aims to streamline healthcare tasks. They highlighted the importance of maintaining a competitive edge in a growing market, with a total addressable market of $260 billion. The call concluded with management expressing optimism about future growth opportunities, particularly through the proposed acquisition of TruBridge and ongoing AI initiatives.

Management highlighted strong financial performance and strategic growth initiatives.

Sourced from an exchange-filed transcript, dated 20 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive13 May 2026
View source filing →

Key takeaway: The investor presentation from Inventurus Knowledge Solutions Limited (IKS) detailed the company's financial results for the quarter and year ended March 31, 2026. IKS reported revenues of INR 8,577 million for Q4 FY26, reflecting an 18% year-over-year growth. The company highlighted a strong EBITDA margin of 35% and a PAT margin of 24%. IKS emphasized its strategic focus on AI-driven healthcare solutions, showcasing partnerships and acquisitions aimed at enhancing its technology capabilities. The presentation also noted the company's commitment to social initiatives through the IKS Cares Foundation, which expanded its healthcare outreach. Management reported a total workforce of 13,331 employees, with a significant portion being clinically trained staff. The document included various metrics indicating strong client relationships and a diversified workforce, alongside recognition for its contributions to women's empowerment in the workplace.

Management highlighted strong financial performance and strategic growth initiatives.

Sourced from an exchange-filed presentation, dated 13 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive29 Apr 2026
View source filing →

Key takeaway: On April 24, 2026, Inventurus Knowledge Solutions Limited (IKS) held a conference call to discuss its strategic acquisition of TruBridge, a provider of healthcare technology solutions for rural hospitals. Management, led by CEO Sachin Gupta, outlined the rationale for the acquisition, emphasizing the opportunity to integrate IKS's platform system of action with TruBridge's electronic health record (EHR) system. Gupta highlighted the potential for improved patient care and operational efficiencies through this integration, particularly in revenue cycle management (RCM). The transaction is valued at $557 million, with IKS anticipating immediate earnings per share accretion. Management noted that the combined entity would have a total addressable market of approximately $600 million in TruBridge's EHR install base and an additional $3 billion in the broader rural healthcare market. The call concluded with management expressing confidence in the long-term strategic benefits of the acquisition.

Management emphasized the strategic advantages and growth opportunities from the acquisition.

Sourced from an exchange-filed transcript, dated 29 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive24 Apr 2026
View source filing →

Key takeaway: The investor presentation detailed Inventurus Knowledge Solutions Limited's (IKS) strategic rationale for acquiring TruBridge, emphasizing the integration of TruBridge's Electronic Health Record (EHR) system with IKS's Care Enablement Platform. Management highlighted the potential for revenue acceleration through existing client bases and identified a $575 million whitespace opportunity for upselling services. The presentation addressed concerns regarding revenue growth post-acquisition, stating that the integration would not distract from core sales efforts. Management reported that owning a clearinghouse would provide operational advantages in Revenue Cycle Management (RCM). The document also discussed the assessment of TruBridge's technology and the plan for integration, including a timeline for realizing synergies and maintaining financial stability post-transaction. Management expressed confidence in managing the associated debt and achieving EPS accretion in the first year after closing.

Management emphasized strategic growth opportunities and operational advantages from the acquisition.

Sourced from an exchange-filed presentation, dated 24 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive23 Apr 2026
View source filing →

Key takeaway: The investor presentation detailed Inventurus Knowledge Solutions Limited's (IKS) agreement to acquire TruBridge, Inc. for an enterprise value of $557 million. Management outlined the strategic rationale behind the acquisition, emphasizing the integration of TruBridge's revenue cycle management (RCM) and electronic health record (EHR) capabilities. The presentation highlighted the fragmented nature of the U.S. RCM market, presenting opportunities for growth, particularly in rural hospitals. Management reported that the acquisition is anticipated to be accretive to profit after tax (PAT) and earnings per share (EPS) in FY27. The document also discussed the value creation potential through enhanced operational efficiencies and a diversified service offering. IKS aims to leverage its AI-driven technology to improve healthcare workflows and patient outcomes. The presentation concluded with a roadmap for the integration of TruBridge into IKS's operations.

Management emphasized growth opportunities and strategic advantages from the acquisition.

Sourced from an exchange-filed presentation, dated 23 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive11 Feb 2026
View source filing →

Key takeaway: The earnings conference call for Inventurus Knowledge Solutions Limited (IKS) on February 5, 2026, highlighted the company's strong performance for Q3 FY 2025-26, reporting a 24% year-on-year revenue growth to INR 815 crores. Management emphasized the strategic shift towards a technology-led, AI-first approach, which has allowed for significant revenue growth with minimal headcount increase, demonstrating operational efficiency. The company discussed its focus on five critical execution pillars, including enhancing its platform capabilities and integrating AI solutions. Management noted successful integration of the AQuity acquisition and ongoing efforts to expand its market share in the healthcare outsourcing sector. The call also addressed the impact of regulatory changes in the U.S. healthcare system and the competitive landscape, asserting that IKS remains well-positioned to capitalize on market opportunities. Overall, the management expressed confidence in sustaining growth and improving operational metrics.

Management highlighted strong financial performance and strategic advancements.

Sourced from an exchange-filed transcript, dated 11 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive04 Feb 2026
View source filing →

Key takeaway: The investor presentation from Inventurus Knowledge Solutions Limited, dated February 4, 2026, detailed the company's financial results for the quarter and nine months ended December 31, 2025. The presentation highlighted a revenue of INR 8,150 million, reflecting a 24% year-over-year growth. The company reported a 35% EBITDA margin and a 22% profit after tax margin, with significant contributions from repeat customers. Management noted a strong client base with over 450 enterprise-level customers and emphasized the importance of their technology-focused workforce. The presentation also outlined strategic initiatives, including the integration of AI-driven solutions and partnerships with major healthcare providers. Awards received, such as the Best in KLAS for Virtual Scribing Services, were mentioned as indicators of the company's market position. Overall, the document conveyed a narrative of growth and operational efficiency.

The presentation emphasized strong financial performance and strategic growth initiatives.

Sourced from an exchange-filed presentation, dated 04 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

AI Summary of Annual Report

AI-generated
FY2025-26146 pages

In FY2026, Inventurus Knowledge Solutions Limited (IKS Health) focused on enhancing its healthcare technology platform through strategic acquisitions and AI integration. The company launched an agentic platform on Google Cloud with a multi-agent handoff and introduced MyCareHub powered by a patented AI model to improve patient engagement. IKS Health acquired TruBridge to secure a trusted clinical backbone for rural hospitals and integrated ThinkDTM's patient engagement engine. The report highlights the company's commitment to building a unified closed-loop system connecting clinical data to financial outcomes, aiming toward a long-term EBITDA target. Corporate social responsibility initiatives included medical camps, education programs, and partnerships with NGOs to support underprivileged communities.

  • Strategic acquisitions of TruBridge and ThinkDTM to strengthen clinical and patient engagement capabilities
  • Development of AI-native agentic platform with multi-agent handoff and patented behavioral intelligence model
  • Integration of Glass Box AI and neuro-symbolic architecture for auditable clinical outcomes
  • Commitment to CSR initiatives focusing on healthcare access, education, and sports development
  • Focus on building a unified closed-loop system connecting clinical intent to financial outcomes

Key takeaway: IKS Health is leveraging strategic acquisitions and AI innovation to build a unified healthcare technology platform, aiming to connect clinical data with financial outcomes while expanding its CSR initiatives to support underserved communities.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 28 Aug 2026View source filing →

Governance disclosures

AI-generated

Needs attention

Regulatory Action (2 items)

Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.

Regulatory Action

2 occurrences

Recent (last 12 months)

Annual Report28 Aug 2026 (FY2025-26)· 3 passages
View source filing →

The company received a show cause notice from the Office of the Development Commissioner, Seepz Special Economic Zone, leading to a penalty of ₹1.75 million imposed on February 24, 2026, which the company paid on March 26, 2026.

Earlier (1-3 years ago)

Annual Report30 Aug 2025 (FY2024-25)· 4 passages
View source filing →

The company paid penalties imposed by RBI for contraventions under the Foreign Exchange Management Act, including late submission fees and compounding orders with specified penalties.

Routine disclosures

Contingent Liability

2 occurrences

Recent (last 12 months)

Annual Report28 Aug 2026 (FY2025-26)· 8 passages
View source filing →

The company has pending litigations related to transfer pricing and direct taxes which may result in a tax incidence of ₹ 49.33 million.

Earlier (1-3 years ago)

Annual Report30 Aug 2025 (FY2024-25)· 5 passages
View source filing →

The company has a contingent liability of ₹0.23 Millions from pending direct tax litigations as of March 31, 2024, and a tax demand of ₹49.10 Million from a transfer pricing adjustment order dated March 17, 2025.

Related-Party Transaction

2 occurrences

Recent (last 12 months)

Annual Report28 Aug 2026 (FY2025-26)
View source filing →

The company has transactions with related parties, including Inventurus Knowledge Solutions Inc., Aquity Solutions India Private Limited, and Aquity Solutions LLC, involving service income, corporate guarantees, loans, and liability transfers.

Earlier (1-3 years ago)

Annual Report30 Aug 2025 (FY2024-25)· 2 passages
View source filing →

The Company has entered into transactions with related parties in compliance with Sections 177 and 188 of the Act. The details of these transactions have been disclosed in the standalone financial statements as required under Indian Accounting Standard 24.

Open full Signal Dashboard →